Max A. Horlbeck

Max A. Horlbeck

Auto-generated profile, based on publicly available information

Max A. Horlbeck

Department of Pediatrics, Division of Genetics and Genomics, Boston Children’s Hospital , Boston, MA 02115

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2016 in eLife
Verified
Journal Article
Open access
MHMax A Horlbeck
Max A Horlbeck
LGLuke A Gilbert
Luke A Gilbert
JVJacqueline E Villalta
Jacqueline E Villalta
BABritt Adamson
Britt Adamson
RPRyan A Pak
Ryan A Pak
JWJonathan S Weissman
Jonathan S Weissman
We recently found that nucleosomes directly block access of CRISPR/Cas9 to DNA (Horlbeck et al., 2016). Here, we build on this observation with a comprehensive algorithm that incorporates chromatin, position, and sequence features to accurately predict highly effective single guide RNAs (sgRNAs) for targeting nuclease-dead Cas9-mediated transcriptional repression (CRISPRi) and activation (CRISPRa). We use this algorithm to design next-generation genome-scale CRISPRi and CRISPRa libraries targeting human and mouse genomes. A CRISPRi screen for essential genes in K562 cells demonstrates that the large majority of sgRNAs are highly active. We also find CRISPRi does not exhibit any detectable non-specific toxicity recently observed with CRISPR nuclease approaches. Precision-recall analysis shows that we detect over 90% of essential genes with minimal false positives using a compact 5 sgRNA/gene library. Our results establish CRISPRi and CRISPRa as premier tools for loss- or gain-of-function studies and provide a general strategy for identifying Cas9 target sites.

23 August 2019 in Science
Verified
Journal Article
Closed access
PDF file
TNThomas M. Norman
Thomas M. Norman
MHMax A. Horlbeck
Max A. Horlbeck
JRJoseph M. Replogle
Joseph M. Replogle
AGAlex Y. Ge
Alex Y. Ge
AXAlbert Xu
Albert Xu
JWJonathan S. Weissman
Jonathan S. Weissman
Manifold destiny: Mapping of genetic interactions (GIs) is usually based on cell fitness as the phenotypic readout, which obscures the mechanistic origin of interactions. Norman et al. developed a framework for mapping and understanding GIs. This approach leverages high-dimensional single-cell RNA sequencing data gathered from CRISPR-mediated, pooled perturbation screens. Diverse transcriptomic phenotypes construct a “manifold” representing all possible states of the cell. Each perturbation and GI projects the cell state to a particular position on this manifold, enabling unbiased ordering of genes in pathways and systematic classifications of GIs. Science , this issue p. 786

13 January 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
MJMarco Jost
Marco Jost
DSDaniel A. Santos
Daniel A. Santos
RSReuben A. Saunders
Reuben A. Saunders
MHMax A. Horlbeck
Max A. Horlbeck
JHJohn S. Hawkins
John S. Hawkins
JWJonathan S. Weissman
Jonathan S. Weissman

23 January 2018 in eLife
Verified
Journal Article
Open access
AMAlexander J Martinko
Alexander J Martinko
CTCharles Truillet
Charles Truillet
OJOlivier Julien
Olivier Julien
JDJuan E Diaz
Juan E Diaz
MHMax A Horlbeck
Max A Horlbeck
JWJames A Wells
James A Wells
While there have been tremendous efforts to target oncogenic RAS signaling from inside the cell, little effort has focused on the cell-surface. Here, we used quantitative surface proteomics to reveal a signature of proteins that are upregulated on cells transformed with KRASG12V, and driven by MAPK pathway signaling. We next generated a toolkit of recombinant antibodies to seven of these RAS-induced proteins. We found that five of these proteins are broadly distributed on cancer cell lines harboring RAS mutations. In parallel, a cell-surface CRISPRi screen identified integrin and Wnt signaling proteins as critical to RAS-transformed cells. We show that antibodies targeting CDCP1, a protein common to our proteomics and CRISPRi datasets, can be leveraged to deliver cytotoxic and immunotherapeutic payloads to RAS-transformed cancer cells and report for RAS signaling status in vivo. Taken together, this work presents a technological platform for attacking RAS from outside the cell.

19 January 2021 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
XYXiaowei Yan
Xiaowei Yan
NSNico Stuurman
Nico Stuurman
SRSusana A. Ribeiro
Susana A. Ribeiro
MTMarvin E. Tanenbaum
Marvin E. Tanenbaum
MHMax A. Horlbeck
Max A. Horlbeck
RVRonald D. Vale
Ronald D. Vale
CRISPR (clustered regularly interspaced short palindromic repeats)-based gene inactivation provides a powerful means for linking genes to particular cellular phenotypes. CRISPR-based screening typically uses large genomic pools of single guide RNAs (sgRNAs). However, this approach is limited to phenotypes that can be enriched by chemical selection or FACS sorting. Here, we developed a microscopy-based approach, which we name optical enrichment, to select cells displaying a particular CRISPR-induced phenotype by automated imaging-based computation, mark them by photoactivation of an expressed photoactivatable fluorescent protein, and then isolate the fluorescent cells using fluorescence-activated cell sorting (FACS). A plugin was developed for the open source software μManager to automate the phenotypic identification and photoactivation of cells, allowing ∼1.5 million individual cells to be screened in 8 h. We used this approach to screen 6,092 sgRNAs targeting 544 genes for their effects on nuclear size regulation and identified 14 bona fide hits. These results present a scalable approach to facilitate imaging-based pooled CRISPR screens.

22 January 2025 in Nature
Verified
Journal Article
Open access
PDF file
YHYan Hu
Yan Hu
MHMax A. Horlbeck
Max A. Horlbeck
RZRuochi Zhang
Ruochi Zhang
SMSai Ma
Sai Ma
RSRojesh Shrestha
Rojesh Shrestha
JBJason D. Buenrostro
Jason D. Buenrostro
Cis-regulatory elements (CREs) control gene expression and are dynamic in their structure and function, reflecting changes in the composition of diverse effector proteins over time1. However, methods for measuring the organization of effector proteins at CREs across the genome are limited, hampering efforts to connect CRE structure to their function in cell fate and disease. Here we developed PRINT, a computational method that identifies footprints of DNA–protein interactions from bulk and single-cell chromatin accessibility data across multiple scales of protein size. Using these multiscale footprints, we created the seq2PRINT framework, which uses deep learning to allow precise inference of transcription factor and nucleosome binding and interprets regulatory logic at CREs. Applying seq2PRINT to single-cell chromatin accessibility data from human bone marrow, we observe sequential establishment and widening of CREs centred on pioneer factors across haematopoiesis. We further discover age-associated alterations in the structure of CREs in murine haematopoietic stem cells, including widespread reduction of nucleosome footprints and gain of de novo identified Ets composite motifs. Collectively, we establish a method for obtaining rich insights into DNA-binding protein dynamics from chromatin accessibility data, and reveal the architecture of regulatory elements across differentiation and ageing.